We are a science-led global healthcare company with a purpose to help people do more, feel better, live longer.
We want to be one of the world’s most innovative, best performing and trusted healthcare company.
Our initiatives at GSK often become a milestone in our journey to attain profitable and sustainable performance.
At GSK we are committed to operating at the highest standards of corporate governance.
Information regarding our codes of conduct, public policies and other reporting information.
we have been serving patients in India for over 90 years.
Patient safety is always our priority and patients, rightly, need to be able to have trust in our products.
Around 40% of the world’s children are immunised against at least one serious disease with a GSK vaccine.
If you are part of general public, please consult your doctor.
Our innovative medicines and vaccines enable millions of people do more, feel better, live longer.
Our people are essential to our success. We focus on building their capabilities, and aim to support and empower them to be the best they can be. In this section you can find out what life at GSK is really like
Graduates can join us in a variety of roles across GSK. Opportunities may be available in your country or you could join via our global schemes.
Looking for a new job? Find out more and apply for a job.
It can take between 10 and 15 years to find a new medicine. Follow the journey to learn why it takes so long.
We know that we won’t discover everything inside our own labs and that we need to partner with other companies, academic institutions and research charities.
Patient safety is always our priority. We evaluate the benefits and risks of potential new medicines throughout the research and development process.
We recognise the importance of publicly disclosing our clinical trial findings and in recent years have made a number of commitments to share more information.
To accelerate the discovery of new medicines and vaccines, we make funding programmes part of our business model.
We have over 400 clinical studies underway involving more than 340,000 patients across 75 countries, helping us to develop medicines and vaccines for the future.
Science can improve health and wellbeing in so many ways, from the development of everyday convenience healthcare products through to life-saving medicines and vaccines.
Find out about how we are addressing healthcare burdens of access, affordability and awareness through our corporate social responsibility initiatives.
Read about how we are embedding our values throughout the business, including the ways we research, develop, sell and market our products.
Learn how we create an inspiring and supportive work environment that encourages our employees to develop their capabilities and achieve their best.
Find out how we are managing the environmental impacts of our operations and products to reduce carbon emissions, water use and waste.
Find out about our responsible business performance in our Responsible Business Supplement and other resources.
Novel Dental Adhesive Resin with Crack Self-healing, Antimicrobial and Remineralization Properties
Periodontitis may lead to Increased Cancer Risk
Characterization and Antibiotic Sensitivity Profile of Bacteria in Orofacial Abscesses of Odontogenic Origin
Combating antibiotic resistance: a survey on the antibiotic prescribing habits of dentists
Dentists in Australia are prescribing some antibiotics inappropriately and there is a preference for moderate-to broad-spectrum agents
India's antibiotic combinations thwart efforts to curb drug resistance, say researchers
Countries step up to tackle antimicrobial resistance
ADA wants federal agencies to provide best practices for managing acute pain
The Impact of Diabetes on Treatment in General Dental Practice
CDC (Centers for Disease Control) reports 'cluster' of dental professionals diagnosed with lung disease
Clostridium difficile-associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis
When Maxillary Sinusitis Does Not Heal: Findings on CBCT Scans of the Sinuses With a Particular Focus on the Occurrence of Odontogenic Causes of Maxillary Sinusitis
Influence of Qualification and Practice Settings of Dental Practitioners on Antimicrobial Prescribing in Delhi and National Capital Region, India
What is risk of infection transmission in dental offices?
Proton pump inhibitors and risk of fractures a meta-analysis of 11 international studies
Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain
Paracetamol for pain relief after surgical removal of lower wisdom teeth
The analgesic pain ladder: a good concept gone astray
Obesity and the risk of dental caries
Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers
Severe periodontitis predicts higher cirrhosis mortality
Periodontitis and incident type 2 diabetes: a prospective cohort study
Patient Education Poster on Periodontal Abscesses
Association between anxiety, obesity and periodontal disease in smokers and non-smokers; A cross sectional study
Periodontal infection may trigger rheumatoid arthritis
Prescribing patterns of dental practitioners in Australia from 2001 - 2012. Part 1: antimicrobials?
Periodontal abscess as a possible oral clinical sign in the diagnosis of undiagnosed diabetes mellitus of elderly in a dental clinic set up - a 7 year old cross-sectional study
Risk of coronary artery disease may be increased in people with untreated endodontic lesions
Antibiotic prescribing by dentists has increased: Why?
Audit and feedback on antibiotic prescribing for dentists